iGenetic Diagnostics: Financial Breakdown
Decoding financial health metrics of iGenetic Diagnostics
Total Revenue₹27.9 Cr-18%Prev. FY
Total Expenses₹35.7 Cr-20%Prev. FY
Profit After Tax₹-7.8 Cr42%Prev. FY
Total Assets₹15.8 Cr-19%Prev. FY
Net Profit Margin-28.1%30%Prev. FY
FAQs on Financials of iGenetic Diagnostics
No. In FY24, iGenetic Diagnostics reported a net loss of ₹7.8 Cr, so it was not profitable.
iGenetic Diagnostics's revenue declined 17.8% year-on-year, from ₹33.9 Cr in FY23 to ₹27.9 Cr in FY24.
iGenetic Diagnostics's estimated EBITDA for FY24 was ₹-4.5 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY24, iGenetic Diagnostics posted revenue of ₹27.9 Cr (down 17.8% YoY) and a net loss of ₹7.8 Cr. Explore the full financials of iGenetic Diagnostics here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links